Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL)

  • Event
  • Aug. 01, 2022, 20:01 UTC
  • 10
  • 1 comments

(35% Negative) Gracell Biotechnologies Inc (was acquired by AstraZeneca (NASDAQ: AZN) on 20/02/2024)) (GRCL) Files Form 6-K

Comment Full text

AstraZeneca (AZN)

  • Event
  • Aug. 01, 2022, 17:16 UTC
  • 11
  • 1 comments

(99% Neutral) AstraZeneca (AZN) Files Form 6-K

Comment Full text

AstraZeneca (AZN)

  • Event
  • Aug. 01, 2022, 15:18 UTC
  • 11
  • 1 comments

(99% Neutral) AstraZeneca (AZN) Files Form 6-K

Comment Full text

AstraZeneca (AZN)

  • Event
  • Aug. 01, 2022, 15:09 UTC
  • 11
  • 1 comments

(99% Neutral) AstraZeneca (AZN) Files Form 6-K

Comment Full text

Genmab (GMAB)

  • Event
  • Aug. 01, 2022, 14:42 UTC
  • 11
  • 1 comments

(99% Neutral) Genmab (GMAB) Files Form 6-K

Comment Full text

Cortexyme Inc (the company was transformed to Quince Therapeutics (QNCX)) (CRTX)

  • Event
  • Aug. 01, 2022, 13:17 UTC
  • 14
  • 1 comments

(85% Positive) CORTEXYME, INC. (CRTX) Announces Clinical Development Update

Comment Full text

Cytokinetics Inc (CYTK)

  • Event
  • Aug. 01, 2022, 13:01 UTC
  • 94
  • 0 comments

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Comment Full text

EAGLE PHARMS INC (EGRX)

  • Event
  • Aug. 01, 2022, 12:31 UTC
  • 14
  • 1 comments

(99% Neutral) Eagle Pharmaceuticals, Inc. (EGRX) Announces Regulatory Update

Comment Full text

OncoCyte Corporation (OCX)

  • Event
  • Aug. 01, 2022, 12:05 UTC
  • 14
  • 1 comments

(94% Neutral) Oncocyte Corporation (OCX) Announces Clinical Development Update

Comment Full text

Chimerix Inc (CMRX)

  • Event
  • Aug. 01, 2022, 11:54 UTC
  • 14
  • 1 comments

(70% Positive) Chimerix, Inc. (CMRX) Announces Business Combination

Comment Full text
  • Previous
  • 145
  • 146
  • 147
  • 148
  • 149
  • Next

Search

News categories

  • Technical Exchange News(10877)
  • Event(2261)
  • SEC News(189431)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124578)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin